No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
C.Q. Pharmaceutical Holding Co., Ltd. is a pharmaceutical company primarily involved in the development, manufacturing, and distribution of medicinal products. Established in 1950, the firm has its headquarters in Chongqing, China. Its historical lineage includes Chongqing Medicines Co., Ltd., which was previously known as the Southwest Branch of China Medicine Company. C.Q. Pharmaceutical Holding Co., Ltd. operates as a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company.
www.cqphar.comNo one on the platform currently holds 000950.SZ.
No tracked institution reports a position in 000950.SZ as of their last filing.
No one on the platform has traded 000950.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.8% | — | — | — | ||
| Rev. Growth % | 2.3% | 12.8% | ||||
| Profit Margin % | 0.5% | 0.9% | 2.1% | |||
| Free Cash Flow Margin % | 0.6% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $83.7B | -3.5% | $0.26 | $0.26–$0.26 | — | 1 |
| 2027 | $88.5B | +5.8% | $0.29 | $0.29–$0.29 | — | 1 |
| 2028 | $93.5B | +5.7% | $0.33 | $0.33–$0.33 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 000950.SZC.Q. Pharmaceutical Holding Co., Ltd. | $5.17 | -1.52% | $8.9B | — |
| 000963.SZHuadong Medicine Co., Ltd | $26.19 | -1.02% | $45.9B | — |
| 002551.SZShenzhen Glory Medical Co.,Ltd. | $3.19 | -3.92% | $2.7B | — |
| 002589.SZRealcan Pharmaceutical Group Co., Ltd. | $2.94 | -6.07% | $3.9B | — |
| 600998.SSJointown Pharmaceutical Group Co., Ltd. |
| $5.02 |
| -1.18% |
| $25.3B |
| — |
| CAHCardinal Health, Inc. | $232.65 | -0.95% | $54.5B | — |
| CORCencora, Inc. | $323.29 | -0.90% | $62.9B | — |
Source: Financial Modeling Prep · peers by sector/industry